A photo of Jack Bleesing.

Jacob "Jack" J.H. Bleesing, MD, PhD


  • Co-Director, Diagnostic Immunology Laboratories
  • Associate Director, Immunodeficiency and Histiocytosis Program
  • Professor, UC Department of Pediatrics

About

Additional Languages

Dutch, German

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in mice. Schmitt, EG; Toth, KA; Risma, SI; Kolicheski, A; Saucier, N; Feliciano BerrĂ­os, RJ; Greenberg, ZJ; Leiding, JW; Bleesing, JJ; Thatayatikom, A; et al. JCI insight. 2022.

Gain-of-function defects in toll-like receptor 8 shed light on the interface between immune system and bone marrow failure disorders. Bleesing, J. Frontiers in Immunology. 2022; 13.

Reduced Intensity Conditioning Allogeneic Transplant for SCID Associated with Cartilage Hair Hypoplasia. Fitch, T; Bleesing, J; Marsh, RA; Chandra, S. Journal of Clinical Immunology. 2022.

Preemptive hematopoietic cell transplantation for asymptomatic patients with X-linked lymphoproliferative syndrome type 1. Tomomasa, D; Booth, C; Bleesing, JJ; Isoda, T; Kobayashi, C; Koike, K; Taketani, T; Sawada, A; Tamura, A; Marsh, RA; et al. Clinical Immunology. 2022; 237.

Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults. Wang, YZ M; Teusink-Cross, A; Elborai, Y; Krupski, MC; Nelson, AS; Grimley, MS; Flannery, A; Mehta, PA; Bleesing, JJ; Chandra, S; et al. Transplantation. 2022; 106:412-419.

T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome. Kumar, D; Prince, C; Bennett, CM; Briones, M; Lucas, L; Russell, A; Patel, K; Chonat, S; Graciaa, S; Edington, H; et al. Blood. 2022; 139:369-383.

International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome. Dimitrova, D; Nademi, Z; Maccari, ME; Ehl, S; Uzel, G; Tomoda, T; Okano, T; Imai, K; Carpenter, B; Ip, W; et al. Journal of Allergy and Clinical Immunology. 2022; 149:410-421.e7.

Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure. Sabulski, A; Myers, KC; Bleesing, JJ; Duell, A; Lane, A; Teusink-Cross, A; Davies, SM; Jodele, S. Blood Advances. 2021; 5:4594-4604.

Daratumumab for the management of autoimmune cytopenias in children and young adults: a case series. Khandelwal, P; Teusink-Cross, A; Kumar, AR; Bleesing, JJ; Mehta, PA; Jordan, MB; Chandra, S; Davies, SM; Marsh, RA. British Journal of Haematology. 2021; 194:e84-e89.

Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function. Aluri, J; Bach, A; Kaviany, S; Chiquetto Paracatu, L; Kitcharoensakkul, M; Walkiewicz, MA; Putnam, CD; Shinawi, M; Saucier, N; Rizzi, EM; et al. Blood. 2021; 137:2450-2462.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey